Variables | Overall survival | Recurrence-free survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Age | 0.998 | 0.979–1.018 | 0.872 | 0.998 | 0.984–1.013 | 0.807 |
Gender (F/M) | 0.922 | 0.481–1.769 | 0.807 | 0.920 | 0.574–1.475 | 0.729 |
HBsAg | 1.581 | 0.908–2.753 | 0.105 | 1.394 | 0.798–2.437 | 0.243 |
AFP (≥400/< 400) | 1.335 | 0.943–1.891 | 0.104 | 1.799 | 1.252–2.586 | 0.001 |
Ascites (+/−) | 1.057 | 0.451–1.986 | 0.884 | 1.693 | 1.025–2.797 | 0.040 |
Tumor size (> 5/≤5) | 1.755 | 1.246–2.530 | 0.002 | 1.440 | 0.998–2.077 | 0.051 |
Multiple tumors | 1.754 | 1.161–2.652 | 0.008 | 1.734 | 1.114–2.698 | 0.015 |
Differentiation (Poor/Well-Moderate) | 1.188 | 0.842–1.678 | 0.327 | 1.081 | 0.751–1.560 | 0.671 |
TNM stage (III/I-II) | 1.325 | 0.902–1.946 | 0.151 | 1.456 | 0.973–2.177 | 0.067 |
Macrovascular invasion | 3.039 | 1.408–6.556 | 0.005 | 2.739 | 1.268–5.915 | 0.010 |
Microvascular invasion | 2.621 | 1.846–3.721 | 0.001 | 2.337 | 1.621–3.369 | 0.001 |
Cirrhosis | 1.191 | 0.832–1.707 | 0.339 | 1.174 | 0.803–1.715 | 0.407 |
NCSTN (high/low) | 1.721 | 1.203–2.460 | 0.003 | 1.566 | 1.080–2.272 | 0.017 |